Quality by design strategies in fluidized bed granulation: A focus on granules for tablet manufacturing

• Autorzy: Przywara Mateusz , Leszczak Patryk

Identyfikatory

DOI

10.12913/22998624/196840

• Języki publikacji: EN

Abstrakty

EN

The study aimed to apply the Quality by Design (QbD) methodology to optimize the fluidized-bed granulation process to produce high-quality pharmaceutical granules intended for tablet manufacturing. Research focused on defining the Quality Target Product Profile (QTPP) and identifying Critical Quality Attributes (CQAs), Critical Material Attributes (CMAs), and Critical Process Parameters (CPPs) crucial to ensuring product quality. The experimental design employed a three-level fractional factorial design to investigate the effects of key process parameters, including the mass flow rate of the binder, the temperature of the inlet air, and the drying time, on the granulation results. Measurements such as particle size distribution, moisture content, and flowability were used to assess the granules. The results indicated that parameters such as the inlet air temperature and drying time significantly impact the quality of the granules, confirming their status as CPPs. Further analysis of tablet mass and hardness revealed that these granule properties directly influenced tablet uniformity and mechanical strength.The application of the failure mode and effect analysis (FMEA) matrix helped to identify and prioritize these critical parameters based on their risk priority number (RPN). The study concluded that a systematic QbD approach, combined with a robust experimental design and risk management, is crucial for optimizing the fluidized-bed granulation process. This ensures consistent production of granules with the desired quality attributes and enhances the safety and efficacy of the final pharmaceutical product.

Słowa kluczowe

EN

flowability; quality by design; process optimization; fluidized bed granulation; granule properties; tablet manufacturing

• Wydawca: Lublin University of Technology ; Polish Society of Ecological Engineering (PTIE), Branch of PTIE in Lublin
• Czasopismo: Advances in Science and Technology. Research Journal
• Rocznik: 2025
• Tom: Vol. 19, no. 2
• Strony: 429--444
• Opis fizyczny: Bibliogr. 42 poz., fig., tab.

Twórcy

autor

Przywara Mateusz

• Department of Chemical and Process Engineering, Rzeszow University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Poland

• https://orcid.org/0000-0001-7009-7811

autor

Leszczak Patryk

• Department of Chemical and Process Engineering, Rzeszow University of Technology, al. Powstańców Warszawy 6, 35-959 Rzeszów, Poland

• https://orcid.org/0009-0001-6050-8872

Bibliografia

• 1. Ming L, Li Z, Wu F, Du R, Feng Y. A two-step approach for fluidized bed granulation in pharmaceutical processing: Assessing different models for design and control. PLoS One. 2017; 12(6).
• 2. Burggraeve A, Monteyne T, Vervaet C, Remon JP, Beer T De. Process analytical tools for monitoring, understanding, and control of pharmaceutical fluidized bed granulation: A review. European Journal of Pharmaceutics and Biopharmaceutics. 2013; 83.
• 3. Sacher S, Khinast JG. An overview of pharmaceutical manufacturing for solid dosage forms. In: Methods in Pharmacology and Toxicology. 2016.
• 4.Yamamoto K, Shao ZJ. Process development, optimization, and scale-up: Fluid-bed granulation. In: Developing Solid Oral Dosage Forms: Pharmaceutical Theory and Practice: Second Edition. 2017.
• 5. Maharjan R, Jeong SH. Application of different models to evaluate the key factors of fluidized bed layering granulation and their influence on granule characteristics. Powder Technol. 2022; 408.
• 6. Mandić J, Pirnat V, Luštrik M, German Ilić I, Vrečer F, Gašperlin M, et al. Solidification of SMEDDS by fluid bed granulation and manufacturing of fast drug release tablets. Int J Pharm. 2020; 583.
• 7. Jain S. Quality by design (QBD): A comprehensive understanding of implementation and challenges in pharmaceuticals development. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6: 29–35.
• 8. Espin MJ, Ebri JMP, Valverde JM. Tensile strength and compressibility of fine CaCO3 powders. Effect of nanosilica addition. Chem Eng J. 2019; 378.
• 9. Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm. 2009; 73(3).
• 10. Saritha D, Bose PSC, Reddy PS, Madhuri G, Nagaraju R. Improved dissolution and micromeritic properties of naproxen from spherical agglomerates: Preparation, in vitro and in vivo characterization. Brazilian J Pharm Sci. 2012; 48(4).
• 11. Yu LX. Pharmaceutical quality by design: Product and process development, understanding, and control. Pharmaceutical Research. 2008; 25.
• 12. CDER/CBER. Guidance for Industry: ICH Q8(R2) Pharmaceutical Development. Guid Ind. 2009; (November).
• 13. Yu LX, Amidon G, Khan MA, Hoag SW, Polli J, Raju GK, et al. Understanding pharmaceutical quality by design. AAPS Journal. 2014, 16.
• 14. Zhang L, Mao S. Application of quality by design in the current drug development. Asian Journal of Pharmaceutical Sciences. 2017, 12.
• 15. Mishra V, Thakur S, Patil A, Shukla A. Quality by design (QbD) approaches in current pharmaceutical set-up. Expert Opinion on Drug Delivery. 2018, 15.
• 16. Raw AS, Furness MS, Gill DS, Adams RC, Holcombe FO, Yu LX. Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs). Adv Drug Deliv Rev. 2004; 56(3).
• 17. Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. In vitro testing of drug absorption for drug “developability” assessment: Forming an interface between in vitro preclinical data and clinical outcome. Current Opinion in Drug Discovery and Development. 2004; 7.
• 18. Jain S. Mechanical properties of powders for compaction and tableting: An overview. Vol. 2, Pharmaceutical Science and Technology Today. 1999.
• 19. Simão J, Chaudhary SA, Ribeiro AJ. Implementation of Quality by Design (QbD) for development of bilayer tablets. European Journal of Pharmaceutical Sciences. 2023; 184.
• 20. Verma RK, Garg S. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. J Pharm Biomed Anal. 2005; 38(4).
• 21. Patil AS, Pethe AM. Quality by design (QbD): A new concept for development of quality pharmaceuticals. Int J Pharm Qual Assur. 2013; 4(2).
• 22. FDA. United States Food and Drug Administration, Guidance for Industry PAT — A Framework for Innovative Pharmaceutical Development, Manufacturing and Quality Assurance. U.S. Department of Health and Human Services. 2004.
• 23. Sangshetti JN, Deshpande M, Zaheer Z, Shinde DB, Arote R. Quality by design approach: Regulatory need. Vol. 10, Arabian Journal of Chemistry. 2017.
• 24. European Medicines Agency. ICH guideline Q10 on pharmaceutical quality system. Eur Med Agency. 2015; 44(1).
• 25. Lee SL, O’Connor TF, Yang X, Cruz CN, Chatterjee S, Madurawe RD, et al. Modernizing pharmaceutical manufacturing: from batch to continuous production. Journal of Pharmaceutical Innovation. 2015; 10.
• 26. Control Q, Chart C. Standard Practice for Process and Measurement Capability Indices 1. Current. 2004; (Reapproved 2012).
• 27. Duggan KC, Walters MJ, Musee J, Harp JM, Kiefer JR, Oates JA, et al. Molecular basis for cyclooxygenase inhibition by the non-steroidal anti-inflammatory drug naproxen. J Biol Chem. 2010; 285(45).
• 28. Djuris J, Medarevic D, Krstic M, Djuric Z, Ibric S. Application of quality by design concepts in the development of fluidized bed granulation and tableting processes. J Pharm Sci. 2013; 102(6).
• 29. Lourenço V, Lochmann D, Reich G, Menezes JC, Herdling T, Schewitz J. A quality by design study applied to an industrial pharmaceutical fluid bed granulation. Eur J Pharm Biopharm. 2012; 81(2).
• 30. Paroha S, Dubey RD, Mallick S. Interaction of naproxen with calcium carbonate: Physicochemical characterization and in vitro drug release studies. Quim Nova. 2014; 37(1).
• 31. Janssen PHM, Depaifve S, Neveu A, Francqui F, Dickhoff BHJ. Impact of powder properties on the rheological behavior of excipients. Pharmaceutics. 2021; 13(8).
• 32. Zode SS, Patil R, Gupta P, Jaladi R, Gautam A, Raghuvanshi R. Assessment of nanosuspension formulation for intranasal administration. Pharm Technol. 2020; 44(9).
• 33. Fonteyne M, Wickström H, Peeters E, Vercruysse J, Ehlers H, Peters BH, et al. Influence of raw material properties upon critical quality attributes of continuously produced granules and tablets. Eur J Pharm Biopharm. 2014; 87(2).
• 34. Opaliński I., Chutkowski M., Stasiak M., Leś K., Olechowski M. Studies on moisture effects on powder flow and mechanochemical improvement of powder flowability. Adv Sci Technol Res J. 2021; 15(2): 228–246.
• 35. Liu B, Wang J, Zeng J, Zhao L, Wang Y, Feng Y, et al. A review of high shear wet granulation for better process understanding, control and product development. Powder Technology. 2021; 381.
• 36. Faqih AMN, Mehrotra A, Hammond SV, Muzzio FJ. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. Int J Pharm. 2007; 336(2).
• 37. Kruszelnicka W, Diviš J, Hlosta J, Gierz Ł, Žurovec D. Calibration of selected bulk biomaterials parameters for DEM simulation of comminution process. Case study – corn and rice grains. Adv Sci Technol Res J. 2022; 16(5).
• 38. Beakawi Al-Hashemi HM, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technology. 2018; 330.
• 39. Shah DS, Moravkar KK, Jha DK, Lonkar V, Amin PD, Chalikwar SS. A concise summary of powder processing methodologies for flow enhancement. Heliyon. 2023; 9.
• 40. Nakamura S, Yamaguchi S, Hiraide R, Iga K, Sakamoto T, Yuasa H. Setting ideal lubricant mixing time for manufacturing tablets by evaluating powder flowability. AAPS PharmSciTech. 2017; 18(7).
• 41. Saravanan M, Sri Nataraj K, Ganesh KS. Hydroxypropyl methylcellulose based cephalexin extended release tablets: Influence of tablet formulation, hardness and storage on in vitro release kinetics. Chem Pharm Bull. 2003; 51(8).
• 42. Narang AS, Breckenridge L, Guo H, Wang J, Wolf A (Avi), Desai D, et al. Assessment of tablet surface hardness by laser ablation and its correlation with the erosion tendency of core tablets. J Pharm Sci. 2017; 106(1).